We at oncgnostics are specialized in the development of in vitro diagnostic tests for all areas of cancer diagnostics.
Our tests are based on epigenetic changes, so called DNA methylations which are characteristic for cancer cells. These highly informative biomarkers, validated and patented by us, represent the core of our products and provide the basis for our activities.
Our business strategy aims in the IVD test development field at, after test validation and initial preclinical trials, cooperation with international partners. After registration, products will be marketed directly or through licensing to cooperation or distribution partners.